StockData

Indaptus Therapeutics, Inc. (INDP) income statement

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$2.82−0.31 (-9.90%)

Close on Nov 20, 2026Market cap $375.74MP/E –Yield –

See a number that looks wrong?